|
|
|
| miR146a Participates in Doxorubicin Cardiotoxicity Through Smad4 |
| QIN Yao, ZHAO Hong-yan, ZHANG Wen-hang, WANG Dong-mei |
| Department of cardiology, Affiliated Hospital of Zunyi Medical College, Zunyi 563003, China |
|
|
|
Abstract Objective:To investigate the mechanism underlying miR146a participating in the cardiotoxicity of doxorubicin. Methods:Rat cardiomyocytes H9c2 were treated with doxorubicin (DOX). After that, the cell viability was detected by CCK-8, the miR146a variation was quantified by qPCR and the change of cleaved Caspase 3 was measured by Western blot (WB). Using CRISPR, two sgRNAs were designed to knockout (KO) the expression of miR146a. The cell viability and cleaved Caspase 3 of miR146a KO cells were respectively detected by CCK-8 and WB. The potential target of miR146a was predicted and validated by luciferase system. The change of target gene after DOX treatment, and the influence of miR146a KO on target gene were detected using WB. Results:After DOX treatment, cell viability decreased, the level of cleaved Caspase 3 elevated and miR146a expression increased 3.6 folds. Using CRISPR, miR146a expression was successfully suppressed, with a much higher inhibitory rate than microRNA decoy (88.6% vs 57.6%). miR146a KO significant impeded DOX induced miR146a elevation, cell viability decrement and cleaved Caspase 3 increment. Smad family member 4(Smad4) was proved to be a target of miR146a by informatics prediction and luciferase experiment. The treatment of cardiomyocytes by DOX led to a decrease of Smad4 expression. In miR146a KO cells, the expression of Smad4 increased, which was not changed by DOX treatment. Conclusions:In rat cardiomyocytes, miR146a participated in doxorubicin cardiotoxicity through Smad4.
|
|
Received: 26 November 2016
Published: 25 June 2017
|
|
|
|
|
[1] Jensen B V, Skovsgaard T, Nielsen S L. Functional monitoring of anthracycline cardiotoxicity:a prospective,blinded,long-term observational study of outcome in 120 patients. Ann Onco,2002,13(5):699-709.
[2] Horie T, Ono K, Nishi H, et al. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway. Cardiovasc Res,2010,87(4):656-664.
[3] He Lin, Hannon G J. MicroRNAs:small RNAs with a big role in gene regulation. Nat Rew Genet,2004,5(7):522-531.
[4] Cong L, Ran F A, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science,2013,339(6121):819-823.
[5] Agarwal V, Bell G W, Nam J W, et al. Predicting effective microRNA target sites in mammalian mRNAs. eLife,2015,4:e05005.
[6] Kutner R H, Zhang X Y, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc,2009,4(4):495-505.
[7] Margaret S E, Joel R N, Phillip A S. MicroRNA sponges:competitive inhibitors of small RNAs in mammalian cells. Nat Methods,2007,4(9):721-726.
[8] Guo Q, Zhang J, Li J, et al. Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells. Blood,2013,131(24):4875-4883.
[9] Derynck R, Zhang Y E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature,2003,425(6958):577-584.
[10] Geraldo M V, Yamashita A S, Kimura E T. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Oncogene,2012,31(15):1910-1922.
[11] He Y, Huang C, Sun X, et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.Cell Signal,2012,24(10):1923-1930.
[12] Jin L, Zhao J, Jing W, et al. Role of miR-146a in human chondrocyte apoptosis in response to mechanical pressure injury in vitro. Int J Mol Med,2014,34(2):451-463.
[13] Xiao A, Wang Z, Hu Y, et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish.Nucleic Acids Res,2013,41(14):e141.
[14] Zhao Y, Dai Z, Liang Y, et al. Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Sci Rep,2014,4:3943. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
